Oragenics (NYSEAMERICAN:OGEN) Shares Up 1.5% – Still a Buy?

Oragenics, Inc. (NYSEAMERICAN:OGEN) shares shot up 1.5% during mid-day trading on Tuesday . The stock traded as high as $1.45 and last traded at $1.37. 219,614 shares traded hands during trading, a decline of 6% from the average session volume of 233,063 shares. The stock had previously closed at $1.35.

Oragenics Trading Up 1.5%

The firm has a 50 day moving average of $1.22 and a 200-day moving average of $2.91. The company has a market cap of $5.66 million, a P/E ratio of -0.06 and a beta of 0.83.

Hedge Funds Weigh In On Oragenics

A hedge fund recently raised its stake in Oragenics stock. Bank of America Corp DE boosted its position in shares of Oragenics, Inc. (NYSEAMERICAN:OGEN) by 7,374.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,546 shares of the company’s stock after buying an additional 15,338 shares during the period. Bank of America Corp DE owned approximately 1.89% of Oragenics worth $59,000 as of its most recent SEC filing. 18.71% of the stock is owned by institutional investors.

About Oragenics

Oragenics, Inc, a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus.